Open Access

Discussion - Dual antiplatelet therapy after an acute coronary syndrome: confronting the disparity between guidelines and clinical practice.

logo

Congress Presentation

About the speakers

Professor Philippe Gabriel Steg

Hospital Bichat-Claude Bernard, Paris (France)
63 presentations
9 followers

Professor Dominick Joseph Angiolillo

University of Florida College of Medicine – Jacksonville, Jacksonville (United States of America)
26 presentations
2 followers

Professor Stefan James

Uppsala University, Uppsala (Sweden)
45 presentations
2 followers

Professor Roxana Mehran

Icahn School of Medicine at Mount Sinai, New York (United States of America)
46 presentations
12 followers

4 more presentations in this session

Welcome and introduction - Dual antiplatelet therapy after an acute coronary syndrome: confronting the disparity between guidelines and clinical practice.

Speaker: Professor P. Steg (Paris, FR)

Thumbnail

Early initiation of dual anti-platelet therapy following an acute coronary syndrome: the clinical reality.

Speaker: Professor S. James (Uppsala, SE)

Thumbnail

Extending the duration of dual antiplatelet therapy - Who could benefit?

Speaker: Professor D. Angiolillo (Jacksonville, US)

Thumbnail

Summary and Close - Dual antiplatelet therapy after an acute coronary syndrome: confronting the disparity between guidelines and clinical practice.

Speaker: Professor R. Mehran (New York, US)

Thumbnail

Access the full session

Dual antiplatelet therapy after an acute coronary syndrome: confronting the disparity between guidelines and clinical practice (EBAC Accredited)

Speakers: Professor P. Steg, Professor D. Angiolillo, Professor S. James, Professor R. Mehran, Professor P. Steg...
Thumbnail

About the event

Image

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb